| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.003 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |